The EV-103 Trial: Enfortumab vedotin plus pembrolizumab and/or chemotherapy for patients with locally advanced or metastatic urothelial cancer Meeting Abstract
| Authors: | Hoimes, C. J.; Rosenberg, J. E.; Petrylak, D. P.; Carret, A. S.; Melhem-Bertrandt, A.; Flaig, T. W. |
| Abstract Title: | The EV-103 Trial: Enfortumab vedotin plus pembrolizumab and/or chemotherapy for patients with locally advanced or metastatic urothelial cancer |
| Meeting Title: | AACR Special Conference on Bladder Cancer: Transforming the Field |
| Journal Title: | Clinical Cancer Research |
| Volume: | 26 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 18-21 |
| Meeting Location: | Denver, CO |
| ISSN: | 1078-0432 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2020-08-01 |
| Start Page: | 43 |
| Language: | English |
| ACCESSION: | WOS:000558688000052 |
| PROVIDER: | wos |
| DOI: | 10.1158/1557-3265.BLADDER19-A23 |
| Notes: | Meeting Abstract: A23 -- Source: Wos |
